Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya

• Váldodahkkit: James K. Kimotho (Dahkki), Abdiaziz A. Gosar (Dahkki), Ronald Inyangala (Dahkki), Paulyne Wairimu (Dahkki), Fred Siyoi (Dahkki), Damaris Matoke-Muhia (Dahkki), Cecilia Wanjala (Dahkki), Jeremiah Zablon (Dahkki), Moses Orina (Dahkki), Lucy Muita (Dahkki), Jacqueline Thiga (Dahkki), Lameck Nyabuti (Dahkki), Eunice Wainaina (Dahkki), Joseph Mwangi (Dahkki), Alice Mumbi (Dahkki), Samuel Omari (Dahkki), Ann Wanjiru (Dahkki), Samson M. Nzou (Dahkki), Missiani Ochwoto (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: AOSIS, 2021-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Timely testing is a key determinant of management outcomes of coronavirus disease 2019 (COVID-19). Real-time reverse transcription polymerase chain reaction tests are currently the mainstay for COVID-19 testing. However, serological point-of-care tests (PoCTs) can be useful in identifyin...